Zenith Healthcare Ltd (530665)

Zenith Healthcare Ltd has announced that Mrs. Neela M. Raycha (DIN: 01258479), Non-Executive Director, retires by rotation at the upcoming 32nd Annual General Meeting and has offered herself for re-appointment. She has been a director on the board since March 13, 2001, and holds 1,261,712 shares in the company. She is the spouse of the Chairman & Managing Director (CMD) and mother of the Joint Managing Director / Whole-Time Director (JMD/WTD).

• Retirement by rotation and proposed re-appointment of Mrs. Neela M. Raycha at the 32nd AGM
• Director holds 1,261,712 equity shares in the company
• On board since March 13, 2001, with qualifications in B.Sc. and LL.B.
• Related to promoters: Spouse of CMD and Mother of JMD/WTD

Zenith Healthcare Limited announced the re-appointment of promoter Mr. Mahendra C. Raycha as Managing Director for a 3-year term from July 1, 2026, to June 30, 2029. The re-appointment at the age of 70 years was approved via special resolution at the 32nd Annual General Meeting. Mr. Raycha holds 66,04,000 equity shares, representing a 12.29% voting stake in the company. The approved remuneration is up to Rs 2,00,000 per month.

• Re-appointed Mr. Mahendra C. Raycha as Managing Director for 3 consecutive years (01/07/2026 to 30/06/2029)
• Special resolution passed as the director has attained the age of 70 years
• Monthly remuneration approved up to Rs 2,00,000 payable periodically
• Promoter-director holds 66,04,000 equity shares representing 12.29% voting rights

Zenith Healthcare has approved the re-appointment of promoter Mr. Mahendra C. Raycha as Managing Director for a 3-year term from July 1, 2026 to June 30, 2029. As he has attained the age of 70 years, the re-appointment requires approval via a special resolution by shareholders. Mr. Raycha holds 6,604,000 equity shares (12.29% voting power) and has served over 20 years as MD. His proposed remuneration is capped at up to Rs. 2,00,000 per month.

• Re-appointment for a term of 3 consecutive years from 01/07/2026 to 30/06/2029
• Monthly remuneration capped up to Rs. 2,00,000 with no change in compensation structure
• Promoter-director holds 6,604,000 equity shares representing 12.29% voting power in personal capacity
• Re-appointment triggered by Section 196 compliance upon reaching 70 years of age

Zenith Healthcare Limited held its 32nd Annual General Meeting on August 28, 2026, via Video Conferencing. Key items tabled for shareholder voting included the adoption of FY26 audited financial statements, the re-appointment of MD Mr. Mahendra C. Raycha, regularization of Joint MD Mr. Akshit M. Raycha, and approval of a material Related Party Transaction with Achyut Healthcare Limited. A total of 39 shareholders attended out of 38,922 registered shareholders. Scrutinizer voting results are expected by September 1, 2026.

• Conducted 32nd AGM on August 28, 2026, commencing at 10:30 AM and concluding in 14 minutes at 10:44 AM.
• A total of 39 shareholders attended the virtual AGM (10 promoter group, 29 public) out of 38,922 total shareholders as of cut-off date August 21, 2026.
• Tabled resolutions for re-appointing Managing Director Mahendra C. Raycha and approving material Related Party Transactions with Achyut Healthcare Ltd.
• Final scrutinizer report and consolidated voting results to be submitted on or before September 1, 2026.

Zenith Healthcare submitted its unaudited financial results for the quarter ended June 30, 2026, following a board meeting on August 14, 2026. The company enters this fiscal year with a TTM revenue of Rs 11 Cr and a thin net worth of Rs 7 Cr. In the preceding quarter (March 2026), the company reported a net loss of Rs 0.34 Cr on revenue of Rs 2.62 Cr. Investors need to verify the detailed P&L to see if the company has returned to profitability, as FY26 annual PAT was just Rs 0.01 Cr.

• Board meeting commenced at 15:00 and concluded at 15:55 on August 14, 2026
• Unaudited financial results for the quarter ended June 30, 2026, were approved with a Limited Review Report
• Company operates with a small TTM revenue base of Rs 11 Cr and a net worth of Rs 7 Cr
• Promoter holding has remained stagnant at 28.74% as of the latest March 2026 filing

Zenith Healthcare's Board of Directors met on August 14, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026. The meeting was brief, lasting 55 minutes, and included the review of the statutory auditor's report. While the specific P&L figures for the quarter were not detailed in the cover letter, the company enters this period with a TTM revenue of Rs 11 Cr and a marginal FY26 profit of Rs 0.01 Cr. This is a routine regulatory filing in compliance with SEBI LODR regulations.

• Board meeting held and concluded on August 14, 2026, between 15:00 and 15:55.
• Approved unaudited financial results for the quarter ended June 30, 2026.
• Company reported a TTM revenue of Rs 11 Cr prior to this announcement.
• Operating profit margin (TTM) stands at -1.4%, indicating ongoing pressure on core profitability.
• Promoter holding remains stable at 28.74% as of the last reporting period.

Zenith Healthcare has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. This follows a fiscal year (FY26) where the company reported a marginal net profit of ₹0.01 Cr on revenues of ₹10.52 Cr. The company is currently operating with thin margins, evidenced by a -1.4% TTM operating profit margin. Investors will be looking for signs of recovery after the March 2026 quarter reported an operating loss of ₹0.46 Cr.

• Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results
• Trading window remains closed until 48 hours after the results declaration
• Company reported a TTM revenue of ₹11 Cr against a net worth of ₹7 Cr
• Previous quarter (March 2026) saw a net loss of ₹0.34 Cr

Zenith Healthcare has approved the re-appointment of Mr. Mahendra C Raycha as Chairman and Managing Director for a three-year term effective July 1, 2026. Since the appointee is 73 years old, the company is seeking shareholder approval via a special resolution at the Annual General Meeting (AGM) on August 28, 2026. The proposed annual remuneration of Rs 24 lakh represents approximately 2.3% of the company's FY26 revenue of Rs 10.52 crore. The company maintains a debt-free status but reported a marginal net profit of only Rs 0.01 crore for FY26.

• Re-appointment of CMD for a 3-year term from July 1, 2026, to June 30, 2029
• Proposed monthly remuneration of Rs 2,00,000, totaling Rs 24 lakh per annum
• CMD Mahendra C Raycha holds 6,604,000 shares, representing 12.29% voting power
• AGM scheduled for August 28, 2026, with a record date of August 21, 2026
• Special resolution required as the appointee has exceeded the age of 70 years

Zenith Healthcare has approved the re-appointment of Mr. Mahendra C Raycha (73) as Chairman and Managing Director for a three-year term effective July 1, 2026. The proposed remuneration is Rs 2,00,000 per month, totaling Rs 24 Lakhs annually, which is significant given the company's FY26 net profit of just Rs 0.01 Cr. As the appointee is over 70 years old, the re-appointment requires a special resolution from shareholders at the upcoming AGM on August 28, 2026. The company remains a micro-cap with TTM revenue of Rs 11 Cr and a debt-free balance sheet.

• Re-appointment of Mahendra C Raycha as MD for a 3-year term from July 1, 2026, to June 30, 2029
• Proposed monthly remuneration of Rs 2,00,000, payable as per company financial convenience
• MD holds 6,604,000 equity shares in his personal name, representing 12.29% voting power
• AGM scheduled for August 28, 2026, with a record date of August 21, 2026, for voting eligibility
• Special resolution required under Section 196 of the Companies Act due to the MD reaching 73 years of age

Zenith Healthcare has filed its 32nd Annual Report for the financial year ending March 31, 2026. The company reported a marginal net profit of ‡0.01 Cr for FY26 on a revenue of ‡10.52 Cr, representing a slight decline from FY25 revenue of ‡11.33 Cr. Operating margins for the full year were negative at -1.24%, reflecting ongoing profitability challenges. Promoter holding remains unchanged at 28.74%, which is relatively low for a micro-cap company.

• 32nd Annual Report submitted for the financial year 2025-26
• FY26 Revenue reported at ‡10.52 Cr versus ‡11.33 Cr in FY25
• Net profit for FY26 was minimal at ‡0.01 Cr
• Operating Profit Margin (OPM) for FY26 stood at -1.24%
• Promoter holding remains stagnant at 28.74% as of March 2026

Zenith Healthcare Ltd has scheduled its 32nd Annual General Meeting (AGM) for August 28, 2026. The company reported a total income of Rs 10.94 crore for FY26, a slight decrease from Rs 11.76 crore in FY25. Profitability experienced a sharp decline, with Profit After Tax (PAT) falling to just Rs 0.51 lakhs from Rs 6.70 lakhs in the previous year. A key agenda item involves a special resolution for related party transactions, where the promoter group (holding 28.74%) will abstain from voting.

• 32nd Annual General Meeting scheduled for August 28, 2026, at 10:30 a.m. via VC/OAVM.
• FY26 Total Income reported at Rs 1,093.65 lakhs (approx. Rs 10.94 Cr).
• FY26 Profit After Tax (PAT) stood at a marginal Rs 0.51 lakhs, down from Rs 6.70 lakhs in FY25.
• Special resolution proposed for related party transactions under Item No. 5 of the notice.
• Promoters and Promoter Group (28.74% stake) to abstain from voting on the related party resolution.

Zenith Healthcare has announced its 32nd Annual General Meeting (AGM) for the financial year 2025-26, scheduled for August 28, 2026. The company has fixed August 21, 2026, as the record date to determine shareholder eligibility for e-voting. The register of members will remain closed from August 22 to August 28, 2026. This is a routine administrative filing for a micro-cap company with a TTM revenue of Rs 11 Cr.

• 32nd Annual General Meeting scheduled for August 28, 2026
• Record date for e-voting eligibility fixed as August 21, 2026
• Book closure period spans 7 days from August 22 to August 28, 2026
• E-voting window open from August 25, 2026 (9:00 AM) to August 27, 2026 (5:00 PM)

Zenith Healthcare has approved the re-appointment of Mr. Mahendra C Raycha as Chairman and Managing Director for a three-year term effective July 1, 2026. The proposed monthly remuneration is up to Rs. 2,00,000 (Rs. 24 lakh per annum), which is notably high compared to the company's FY26 Profit After Tax of just Rs. 0.51 lakhs. A special resolution is required for this appointment as the MD is 73 years old, exceeding the standard age limit of 70. The company's 32nd Annual General Meeting (AGM) is set for August 28, 2026.

• Re-appointment of Mr. Mahendra C Raycha as MD from July 1, 2026, to June 30, 2029.
• Proposed annual remuneration of up to Rs. 24,00,000, subject to shareholder approval.
• MD holds 6,604,000 equity shares, representing a 12.29% voting stake.
• AGM scheduled for August 28, 2026, with a record date of August 21, 2026.
• Company reported a thin Profit After Tax of Rs. 0.51 lakhs for FY26 on revenue of Rs. 10.93 Cr.

Zenith Healthcare has scheduled its 32nd Annual General Meeting (AGM) for August 28, 2026, with a record date of August 21, 2026. The Board has proposed the re-appointment of Mr. Mahendra C Raycha (73) as Chairman and Managing Director for a three-year term starting July 1, 2026. The proposed remuneration is up to ₹2,00,000 per month (₹24 lakh per annum), which is significant given the company's FY26 Profit After Tax of just ₹0.51 lakhs. The company remains a micro-cap with FY26 total income of ₹10.94 crore and zero debt.

• AGM scheduled for August 28, 2026, to be held via VC/OAVM
• Record date for voting eligibility fixed as August 21, 2026
• Proposed re-appointment of MD Mahendra C Raycha for a 3-year term until June 2029
• Proposed MD remuneration of up to ₹2,00,000 per month (₹24,00,000 per annum)
• FY26 Profit After Tax reported at ₹0.51 lakhs on a total income of ₹1,093.65 lakhs